Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18413-18419
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18413
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18413
Table 2 Main side effects of the 51 patients
| Type | Side effects degree | Sum | |||
| I | II | III | IV | ||
| Bone marrow suppression | |||||
| leukopenia | 6 | 9 | 10 | 13 | 38 |
| Thrombocytopenia | 5 | 3 | 4 | 1 | 13 |
| anemia | 6 | 5 | 2 | 1 | 14 |
| Gastrointestinal reactions | |||||
| Nausea, vomiting | 23 | 14 | 8 | 3 | 48 |
| SGOT/SGPT | 5 | 4 | 2 | 0 | 11 |
| Diarrhea | 8 | 4 | 0 | 0 | 12 |
| Oral mucositis | 7 | 8 | 4 | 1 | 20 |
| Baldness | 17 | 5 | 3 | 0 | 25 |
| Peripheral neuritis | 12 | 1 | 0 | 0 | 13 |
| Urea nitrogen | 4 | 2 | 0 | 0 | 6 |
| Creatinine | 3 | 1 | 0 | 0 | 4 |
- Citation: Yu YJ, Sun WJ, Lu MD, Wang FH, Qi DS, Zhang Y, Li PH, Huang H, You T, Zheng ZQ. Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage III/IV gastric cancer. World J Gastroenterol 2014; 20(48): 18413-18419
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18413.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18413